Cancer Predisposition Syndromes Flashcards
1
Q
11p15
abnormalities
A
- BWS: Methylation defects or uniparental disomy of 11p15
- 10% lifetime risk of several cancers, including
1. Wilms tumor (43%)
2. Hepatoblastoma (20%)
3. Adrenal cortical carcinoma (7%)
4. Neuroblastoma
5. RMS
2
Q
DICER1
A
- DICER1 syndrome: Mutations in DICER1 disrupt the processing of miRNAs and predispose to:
1. PPB
2. Thyroid/multinodular goiter
3. Cystic nephroma
4. Botryoid RMS
5. Sertoli-Leydig sex cord-stromal tumors
Ciliary body medulloepithelioma
3
Q
RB1
A
- Inherited Retinoblastoma: Associated with:
1. Osteosarcoma
(25-40%; radiation!)
2. Pineoblastoma (trilateral retinoblastoma)
3. Soft tissue sarcomas
(10-15%; leiomyosarcoma > fibrosarcoma > NRSTS > RMS)
4. Melanoma
(15-20%)
4
Q
TP53
A
- Li-Fraumeni syndrome: Very high risk of cancer:
1. Sarcomas (soft tissue and osteosarcoma)
2. Malignant glioma
3. Low-hypodiploid ALL (31-39 chromosomes)
4. Choroid plexus carcinoma
5. Adrenocortical carcinoma
5
Q
TSC1/TSC2
A
- Tuberous sclerosis: Mutations in TSC1/2
- Hypopigmented lesions (“ash-leaf” macules), facial angiofibromas, benign hamartomas (“tubers”) throughout the body, subependymal giant cell astrocytomas
(MTOR inhibitor), renal cell carcinoma.
6
Q
ATM
A
- Ataxia-telangiectasia syndrome: ATM is vital in DNA repair
- Characterized by:
1. Ataxia and chorea when young
2. Telangiectasia later in life
3. Immunodeficiency and infections
4. Risk of developing leukemia and lymphoma
5. Sensitivity to ionizing radiation
7
Q
PTCH1
A
- Gorlin syndrome: Aka. nevoid basal cell carcinoma syndrome
- Associated with:
1. Basal cell carcinoma
2. 2. Benign jaw tumors (keratocystic odontogenic tumors)
3. An increased incidence of medulloblastoma (SHH subtype, as PTCH1 is in the SHH pathway)
8
Q
PTEN
KLLN
SDHB
SDHD
A
- Cowden syndrome: Characterized by
1. Benign hamartomas
2. Predisposition to breast and endometrial cancer (85%)
3. Thyroid cancer (35%)
4. Papillary RCC (35%) - Most common mutations in PTEN
9
Q
PTPN11
SOS1
RAF1
RIT1
A
- Noonan syndrome: Affect the RAS/MAPK pathway
- Characterized by
1. Facial dysmorphism
2. Short stature
3. Congenital heart disease (e.g., pulmonary stenosis)
4. Increased risk of JMML, neuroblastoma, and ERMS
10
Q
RECQL4
A
- Rothmund-Thomson syndrome: Biallelic mutations
- Significant predispo to osteosarcoma (30% incidence)
- Associated with facial/extremity rash in infancy, sparse scalp hair, juvenile-onset cataracts, musculoskeletal defects
11
Q
RET2
A
- Multiple endocrine neoplasia type 2 (MEN2): Both type 2A and 2B have an increased risk of medullary thyroid carcinoma and pheochromocytoma
- MEN 2A also involves an increased risk for parathyroid adenoma
- MEN 2B is associated with mucosal neuromas and a marfanoid habitus
12
Q
RUNX1 (AML1)
A
- Familial platelet disorder with predisposition to AML: Have qualitative and quantitative platelet defects
13
Q
VHL
A
- von Hippel-Lindau disease: Autosomal dominant
- Associated with benign (hemangioblastomas in the CNS) and cancerous (renal cell carcinoma, pheochromocytoma) tumors
- Tumors occurrence in young adulthood
14
Q
CXCR4
A
- WHIM syndrome: Gain of function mutation
- Characterized by warts, hypogammaglobulinemia, infections, and myelokathexis (neutrophils stuck in the bone marrow)
15
Q
GATA2
A
- MonoMAC syndrome: Monocytopenia, B and NK cytopenia, and atypical mycobacterial infection
- Familial AML
- Emberger syndrome: Lymphedema, warts, and predisposition to AML/MDS
16
Q
HPS2 (aka AP3B1)
A
- Hermansky-Pudlack syndrome type 2: Autosomal recessive
- Characterized by:
1. Albinism
2. Neutropenia and immune deficiency
3. Platelet defects (dense granules)
4. Propensity to develop HLH
5. Pulmonary fibrosis
17
Q
LYST
A
- Chediak Higashi: Autosomal recessive mutations
- Characterized by:
1. Albinism with giant granules in myeloid cells
2. Platelet defects (dense granules)
3. Propensity to develop HLH
18
Q
RAB27A
A
- Griscelli syndrome type 2: Autosomal recessive
- Characterized by partial albinism (silver hair) and a propensity to HLH
19
Q
SH2D1A
XIAP
A
- XLPS: Associated with
1. Immunodeficiency (B cells present but dys-/hypogammaglobulinemia)
2. Fulminant infections with EBV
20
Q
STAT3
TYK2
DOCK
A
- Job’s syndrome (aka. Hyper-IgE syndrome): autosomal dominant (STAT3) or recessive (TYK2, DOCK8) defects in JAK-STAT signaling
- Associated with defective
1. Immunodeficiency (neutrophil chemotaxis, T cell function, very elevated IgE, and eosinophilia)
2. Coarse facies
3. Severe skin, sinus, and pulmonary infections - Patients require antimicrobial prophylaxis
21
Q
ALAS2
A
- X-linked sideroblastic anemia: ALAS2 encodes for the erythroid ALA-synthase that is part of the heme production synthesis
- Results in accumulation of erythroblasts with excess iron
- Visualization with Prussian Blue stain in the bone marrow
- Peripheral blood has two RBC populations (normocytic and microcytic)
22
Q
CYB5R1-4
A
- Cytochrome b5 reductase deficiency: Autosomal recessive methemoglobinemia
- Type 1: Only RBCs are deficient in cytochrome b5 reductase resulting in lifelong
methemoglobinemia, cyanosis, physiologic adaptation - Type 2: All cells are deficient resulting in Type 1 symptoms, neurological complications, and death within the first year of life
23
Q
F8 Inv22
A
- Hemophilia A: Factor VIII intron 22 inversion with truncated protein
- Causes severe hemophilia A in 50% of patients
24
Q
GPI Deficiency
A
- Glucose phosphate isomerase deficiency: 2nd most common hereditary nonspherocytic hemolytic anemia
- Enzymopathy affecting anaerobic glycolysis and increased splenic clearance of RBCs
- Associated with neurologic impairment
25
Q
HBM
A
- Inherited methemoglobinemia (α58 His→Tyr): Hgb variant with ferric iron
- Patients are asymptomatic despite high levels of methemoglobin
26
Q
P5N
A
- Pyrimidine 5’-nucleotidase deficiency: Autosomal recessive non-spherocytic hemolytic anemia
- Characterized by basophilic stippling
- Of note, lead toxicity inhibits pyrimidine 5’-nucleotidase and exhibits basophilic stippling
27
Q
PKLR
A
- Pyruvate kinase deficiency: Most common hereditary non-spherocytic hemolytic anemia
- Enzymopathy affecting anaerobic glycolysis and splenic clearance of RBCs
28
Q
TMPRSS6
A
- Iron-refractory iron deficiency anemia (IRIDA): Autosomal recessive
- Increased expression of the iron regulatory hormone hepcidin, which results in iron deficiency anemia that is refractory to oral iron and only partly responsive to
parenteral iron
29
Q
Adrenocortical Carcinoma
A
Li Fraumeni - TP53
Beckwith-Widemann - 11p15.5
30
Q
Choroid Plexus Carcinoma, Anaplastic RMS, Hypodiploid ALL
A
Li Fraumeni - TP53
31
Q
Desmoid Tumor
A
FAP - APC
32
Q
Hepatoblastoma
A
Beckwith-Wideman - 11p15.5
FAP - APC
33
Q
JMML
A
NF1 - NF1
Noonan - PTPN11, KRAS
34
Q
Medullary Thyroid Carcinoma
A
MEN 2A/B - RET